共 82 条
[1]
Moxley JH(1980)Treatment of primary breast cancer: Summary of the National Institutes of Health Consensus Development Conference JAMA 244 797-803
[2]
Allegra JC(1985)Adjuvant Therapy for Breast Cancer, November 1-3, 2000 Adjuvant chemotherapy for breast cancer.JAMA 254 3461-3463
[3]
Henney J(1991)Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999 Treatment of early-stage breast cancer.JAMA 265 391-395
[4]
Fitzgibbons PL(2001)Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer J Natl Cancer Inst 93 979-989
[5]
Page DL(2000)Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Arch Pathol Lab Med 124 966-978
[6]
Weaver D(2000)Tamoxifen for early breast cancer: an overview of the randomized trials N Engl J Med 342 525- 533
[7]
Braun S(2000)Chemotherapy with or without tamoxifen for patients with ER-negative breast cancer and negative nodes: Results from NSABP B-23 Lancet 55 1869-1874
[8]
Pantel K(1998)CMF versus CAF with and without tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients: first results of intergroup trial INT 0102 Lancet 351 1451-1467
[9]
Muller P(2000)Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer Proc Am Soc Clin Oncol 19 72a-72a
[10]
Aebi S(1998)Postchemotherapy adjuvant tamoxifen beyond five years in patients with lymph node-positive breast cancer Proc Am Soc Clin Oncol 17 1a-1a